1 – 20 of 28
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
(
- Contribution to journal › Article
- 2006
-
Mark
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
(
- Contribution to journal › Article
- 2005
-
Mark
Urinary osteocalcin as a marker of bone metabolism
(
- Contribution to journal › Article
-
Mark
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
(
- Contribution to journal › Article
-
Mark
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
(
- Contribution to journal › Article
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
(
- Contribution to journal › Article
- 2004
-
Mark
Development of sensitive immunoassays for free and total human glandular kallikrein 2
(
- Contribution to journal › Article
- 2003
-
Mark
Identification of novel proteolytic forms of osteocalcin in human urine
(
- Contribution to journal › Article
- 2002
-
Mark
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step
(
- Contribution to journal › Article
-
Mark
Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease
(
- Contribution to journal › Article
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
(
- Contribution to journal › Article
- 2001
-
Mark
Species-specific alkaline phosphatase activity in freshwater spring phytoplankton: Application of a novel method
(
- Contribution to journal › Article
-
Mark
Low incidence of toxoplasma infection during pregnancy and in newborn in Sweden
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
(
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article
-
Mark
Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum
(
- Contribution to journal › Article
- 1999
-
Mark
Time-resolved fluorescence imaging (TRFI) for direct immunofluorescence of PSA and alpha-1-antichymotrypsin in prostatic tissue sections
(
- Contribution to journal › Article
-
Mark
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects
(
- Contribution to journal › Article
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article